Supernus Pharmaceuticals Inc (SUPN)
Financing Cash Flow
$31.51M
TTM · Period ending: · USD
SUPN Financing Cash Flow
Latest reported$31.51Mperiod ending
Latest reported$31.51Mperiod ending
SUPN TTM Cash from Financing ($27.09M → $31.51M)
TTM financing cash flow
High-resolution chart · PNG
SUPN financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 31,509,000 | |
| 39,644,000 | |
| 9,130,000 | |
| 6,494,000 | |
| -11,499,000 | |
| -10,776,000 | |
| 12,193,000 | |
| 7,395,000 | |
| 4,090,000 | |
| -476,484,000 | |
| -397,880,000 | |
| -396,143,000 | |
| -389,458,000 | |
| 91,731,000 | |
| -10,477,000 | |
| -150,046,000 | |
| -155,177,000 | |
| -154,701,000 | |
| -130,420,000 | |
| 9,389,000 | |
| 7,086,000 | |
| 5,774,000 | |
| 3,559,000 | |
| 1,753,000 | |
| 2,974,000 | |
| 3,177,000 | |
| 3,928,000 | |
| 3,916,000 | |
| 4,502,000 | |
| 9,508,000 | |
| 376,438,000 | |
| 376,358,000 | |
| 377,876,000 | |
| 372,790,000 | |
| 5,681,000 | |
| 5,307,000 | |
| 3,221,000 | |
| 2,532,000 | |
| 2,052,000 | |
| 2,055,000 | |
| 1,853,000 | |
| 1,844,000 | |
| 1,867,000 | |
| 1,373,000 | |
| 1,329,000 | |
| 712,000 | |
| 570,000 | |
| -1,190,000 | |
| -1,222,000 | |
| 63,765,000 | |
| 62,739,000 | |
| 106,569,000 | |
| 104,362,000 | |
| 87,952,000 | |
| 87,916,000 | |
| 60,427,000 | |
| 61,335,000 | |
| 13,425,000 | |
| 27,087,000 | |
| 10,843,689 | |
| 13,895,304 |